Q517--Pharmalink-Reverse Pharmaceutical (VA-23-00020246)
Page 5 of 5 DEPARTMENT OF VETERANS AFFAIRS Network Contracting Office 6 (NCO 6) Sources Sought 36C24623Q0392 In accordance with FAR 15.201(e), responses to this notice are not offers and cannot be acc... Page 5 of 5 DEPARTMENT OF VETERANS AFFAIRS Network Contracting Office 6 (NCO 6) Sources Sought 36C24623Q0392 In accordance with FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Additionally, the Government reserves the right to revise the Performance Work Statement, Statement of Work and/or other contract requirements before the release of any associated solicitation. This notice is not a Request for Proposals (RFP) or Request for Quotes (RFQ). Information provided in this notice is subject to change prior to release of a solicitation. OVERVIEW The Department of Veterans Affairs, Network Contracting Office 6 is conducting market research to identify potential sources for handling medication returns, refunds, and disposal services supporting the Salisbury VCA Healthcare System (SVAHCS) in Salisbury, North Carolina. Forward all questions to the Contracting Officer identified below. SCOPE OF WORK The Salisbury VA Healthcare System, Salisbury, North Carolina, has a need of services for medication returns, refunds, and disposal services. The period of performance will be from March 1, 2023, through February 28, 2024, and the anticipated contract may include option years. Services would include the following: Summary of Services PLI shall perform the services as set forth in this SOW in compliance with all applicable federal, state and local laws, rules, and regulations. Deliverables PLI Detailed Return Inventory reports. Certificates of Destruction. Non-returnable Inventory Reports. Corporate Level Reports upon request. Customer Monthly report of credits received directly from Manufacturer or Wholesaler for return product processed by PLI. Obligations of PLI PLI shall provide Company with Pharmaceutical Return and Disposal Services, including but not limited to: Ground shipping, via common carrier, from the returning facility to the PLI processing facility. Processing of returned products to determine credit eligibility according to the Manufacturer s and/or Wholesaler s return policy. Shipment of returnable product to pharmaceutical Manufacturer for credit. Sortation, characterization, and profiling of non-returnable merchandise. Disposal of non-returnable products via incineration. Application and execution of product return authorizations. Product staging and handling. Detailed return inventory reports and certificates of destruction. Access to web-based inventory and reporting applications. Storage and tracking of Future dated product. Conduct a minimum of six (6) services for the initial year and a minimum of eleven pick-ups for the option year based on VAMC Pharmacy needs Monthly returns shall be scheduled with the pharmacy on second Tuesday of every month Provide on-site pick-up services at least monthly. Schedule Services via Outlook Calendar with Confirmation a. Manufacturer Return Process PLI will obtain and complete all Manufacturers return authorizations. Through standard returns processing, the manufacturer issues the following types of credit: wholesaler credit, direct reimbursement check, or exchange product. The method and amount of credit issued is determined solely by the manufacturer therefore PLI does not guarantee or warrant the provision of a refund or credit. The time period for credit issuance by a Manufacturer varies based on the Manufacturer s return policy. b. Disposal Process PLI will only process viable products that have a reasonable expectation of credit. Customer shall not send PLI any products that do not meet the definition of a viable product. Non-returnable items will be documented in a non-returnable inventory indicating product name, NDC, quantity, and the reason for non-eligibility for credit. All non-viable/non-returnable items will be destroyed via incineration and a Certificate of Destruction shall be provided to the returning facility. The Customer will be invoiced at the current per pound disposal rate. c. Reports PLI will provide return detail reports by Manufacturer after processing all returns. This report will include product name, national drug code (NDC), lot number, quantity, and estimated return value (ERV). These reports will be available upon completion of each return and available on the PLI website. Corporate Level reports will be available to designated Customer personnel. d. Return Service Components Return Preparation & Support Service: Easy to use web-based reporting application Management and generation of user names and passwords for facility users Setup site and product records in databases and systems Customer formulary and pricing import if customer price file is not made available to PLI, industry WAC will be used for pricing. Customize Return Policy and RA databases Verification of Site licensing and credentials Facility and User Training Return Processing Services & Systems Maintenance: Password resets, changes, and maintenance Project management and reporting Receipt and documentation of packages from facilities Process Return within 14 days of receipt at PLI Physical processing and reconciliation of received product Data entry to systems and material handling DEA 222 form management Waste characterization, inventory, and disposal of non-returnable products Storage of packages prior to processing and disposal Preparation and submittal of RA s to Manufacturer Random quality control and processing validation Post-Return Services: Witness and Certification of Destruction Return Processing Reports Credit distribution to returning facilities Credit research and reconciliation Customer service and Help Desk for facilities and users Customer Responsibilities Provide PLI with current price file, if available, prior to first shipment otherwise standard industry WAC will used to determine ERV. Comply with all federal, state and local regulations regarding the packaging and shipment of pharmaceuticals to PLI. Provide PLI with accurate representative inventory of shipments. Send viable product only. Appointment of Customer representative to manage account. Provide PLI with an authorization letter allowing PLI to contact Manufacturers and Wholesalers on behalf of the Customer for credit processing. Provide PLI with assistance in researching credit status with Manufacturers and Wholesalers as requested. If on-site, Customer representative must oversee service. SMALL BUSINESS REQUIREMENTS For market research purposes, all responses to this notice will be reviewed, regardless of small business/socioeconomic category, including those firms that are identified as large businesses. Review of responses to this notice will support later determination of set-aside requirements, if a solicitation becomes available, where the rule of two is met regarding a set-aside, including set-asides under 38 U.S.C. 8127 and 8128 for Service-Disabled Veteran Owned Small Businesses (SDVOSB) and/or Veteran Owned Small Businesses (VOSB) firms registered in the Vendor Information Pages (VIP) database, in accordance with priorities set by regulation. NAICS CODE: 325412 Pharmaceutical Preparation Manufacturing PRODUCT OR SERVICE CODE (PSC): Q517, Medical- Pharmacology INSTRUCTIONS FOR RESPONDING: Interested companies can respond, via email, to Monique.Cordero@va.gov, with the following information: (1.) Company Point of Contact, including name, title, phone number and email address. (2.) Company name, DUNS number, small business/socioeconomic status of the company, and address of the applicable office. (3.) Any relevant certifications and/or licenses to perform these services. Additional information may be requested by the Contracting Officer at a later time. POINT OF CONTACT: Monique Cordero Contracting Specialist Services Team 3 Network Contracting Office (NCO) 6 Regional Procurement Office (RPO) East Veterans Health Administration U.S. Department of Veterans Affairs Monique.Cordero@va.gov DUE DATE FOR RESPONSES: This notice will close on Tuesday, February 7, 2023, at 10:00AM Eastern Time. CONTRACTOR RESPONSIBILITY A potential source, for the purposes of this notice, is considered to be any company meeting the following requirements. Some of the below requirements may be modified prior to release of any solicitation. 1. The potential source would meet the requirements of the relevant Limitations on Subcontracting clauses of the FAR. 2. The potential source is registered in the System for Award Management (SAM) database at https://www.sam.gov, as whichever entity/office that would receive award in the event of a solicitation. 3. The potential source is registered in the Vendor Information Pages (VIP) database at http://www.va.gov/osdbu, if applicable. (This is only applicable to firms meeting Small Business Administration (SBA) and VA requirements for Service-Disabled Veteran-Owned Small Business (SDVOSB) or Veteran-Owned Small Business (VOSB) programs.) 4. The potential source has favorable (satisfactory) past performance information for federal contracts, if applicable, as documented in Government databases, including the Federal Awardee Performance and Integrity Information System (FAPIIS) and Past Performance Information Retrieval System (PPIRS), where applicable.
Links ()
Attachments ()
Data sourced from SAM.gov.
View Official Posting »